Scripps 7th Annual Cardiomyopathy and Cardio-Oncology Symposium 2024 (Videos + PDF)

Advanced Education in Cardiomyopathies, Cardiac Amyloidosis, Cardio-Oncology, and Cancer-Related Cardiovascular Disease

The Scripps 7th Annual Cardiomyopathy and Cardio-Oncology Symposium 2024 is a comprehensive cardiovascular education program developed by Scripps Health and Scripps Conference Services & CME. This state-of-the-art symposium focuses on the rapidly evolving fields of cardiomyopathy and cardio-oncology, providing clinicians with practical guidance on the diagnosis, treatment, and long-term management of patients with complex myocardial diseases and cancer-related cardiovascular complications.

Featuring nationally recognized experts in cardiology, heart failure, imaging, oncology, genetics, and cardio-oncology, the program reviews the latest evidence surrounding cardiac amyloidosis, hypertrophic cardiomyopathy, cardiac sarcoidosis, genetic cardiomyopathies, chemotherapy-related cardiotoxicity, and cardiovascular care of cancer survivors.

Format: 29 Videos + 1 PDF
File Size: 3.47 GB
Year: 2024

Course Overview

Advances in cancer treatment have significantly improved survival rates, creating a growing population of cancer survivors who face cardiovascular complications resulting from chemotherapy, radiation therapy, targeted therapies, and immunotherapies.

At the same time, major breakthroughs in the diagnosis and treatment of cardiomyopathies—particularly cardiac amyloidosis and hypertrophic cardiomyopathy—have transformed clinical practice.

This symposium provides a multidisciplinary approach to understanding these complex diseases while emphasizing evidence-based management strategies that improve both cardiovascular and oncologic outcomes.

Target Audience

This course is designed for:

Physicians

• Cardiologists

• Heart Failure Specialists

• Oncologists

• Hematologists

• Internal Medicine Physicians

• Cardiovascular Imaging Specialists

Advanced Practice Providers

• Nurse Practitioners

• Physician Assistants

• Clinical Nurse Specialists

Allied Health Professionals

• Pharmacists

• Cardiac Nurses

• Oncology Nurses

• Allied Healthcare Professionals

Learning Objectives

After completing this symposium, participants should be able to:

• Evaluate current and emerging treatments for cardiac amyloidosis

• Diagnose and manage cardiac sarcoidosis

• Assess genetic cardiomyopathies and appropriate testing strategies

• Implement best practices in cardio-oncology care

• Monitor and manage chemotherapy-induced cardiotoxicity

• Prevent and treat cardiovascular complications in cancer patients

• Manage venous thromboembolism in oncology patients

• Develop long-term cardiovascular surveillance plans for cancer survivors

• Integrate multidisciplinary care approaches into clinical practice

Cardiac Amyloidosis

Diagnosis and Evaluation

Topics Covered

• Transthyretin Amyloidosis (ATTR)

• Light Chain Amyloidosis (AL)

• Echocardiographic Findings

• Cardiac MRI Assessment

• Nuclear Imaging Techniques

• Early Recognition Strategies

Emerging Treatments

Areas Covered

• Disease-Modifying Therapies

• TTR Stabilizers

• Novel Therapeutic Agents

• Clinical Trial Updates

• Long-Term Patient Management

Hypertrophic Cardiomyopathy (HCM)

Contemporary Management

Topics Include

• Genetic Basis of HCM

• Risk Stratification

• Sudden Cardiac Death Prevention

• Medical Therapy

• Septal Reduction Therapy

• Novel Myosin Inhibitors

Genetic Testing

Areas Covered

• Family Screening

• Genetic Counseling

• Inherited Cardiomyopathy Evaluation

• Precision Medicine Approaches

Cardiac Sarcoidosis

Diagnosis and Treatment

Topics Covered

• Clinical Presentation

• Advanced Imaging

• PET Imaging

• Cardiac MRI

• Immunosuppressive Therapy

• Arrhythmia Management

Genetic Cardiomyopathies

Inherited Heart Muscle Disorders

Topics Include

• Dilated Cardiomyopathy

• Arrhythmogenic Cardiomyopathy

• Restrictive Cardiomyopathy

• Genetic Testing Strategies

• Family Risk Assessment

Cardio-Oncology

Cancer Therapy–Related Cardiotoxicity

Topics Covered

• Anthracycline Cardiotoxicity

• HER2-Targeted Therapy

• Immunotherapy Complications

• Radiation-Induced Heart Disease

• Targeted Therapy Cardiovascular Effects

Cardiac Monitoring During Cancer Treatment

Areas Covered

• Echocardiographic Surveillance

• Global Longitudinal Strain

• Biomarker Assessment

• Early Detection Strategies

• Risk-Based Monitoring Protocols

Cancer Survivorship and Cardiovascular Health

Long-Term Follow-Up

Topics Include

• Cardiovascular Risk Assessment

• Survivorship Care Models

• Prevention Strategies

• Ongoing Cardiac Monitoring

• Quality of Life Considerations

Venous Thromboembolism (VTE) in Cancer

Cancer-Associated Thrombosis

Areas Covered

• Risk Stratification

• Prevention Strategies

• Anticoagulation Management

• Special Clinical Scenarios

• Long-Term Treatment Considerations

Heart Failure in Oncology Patients

Cardiomyopathy and Heart Failure Management

Topics Covered

• Cancer Therapy–Induced Heart Failure

• Guideline-Directed Medical Therapy

• Advanced Heart Failure Care

• Multidisciplinary Management

Advanced Cardiovascular Imaging

Imaging Modalities

Topics Include

• Echocardiography

• Strain Imaging

• Cardiac MRI

• Nuclear Imaging

• PET Imaging

• Multimodality Diagnostic Approaches

Multidisciplinary Cardio-Oncology Care

Team-Based Management

Areas Covered

• Cardiology-Oncology Collaboration

• Treatment Planning

• Shared Decision-Making

• Risk Reduction Strategies

• Coordinated Long-Term Care

Educational Highlights

Expert National Faculty

Learn from recognized leaders in cardiomyopathy, heart failure, imaging, genetics, and cardio-oncology.

Practical Clinical Focus

Emphasizes evidence-based recommendations applicable to daily clinical practice.

Multidisciplinary Perspective

Combines expertise from cardiology, oncology, imaging, and genetics.

Emerging Therapies

Reviews the latest treatments transforming care for amyloidosis, HCM, and cancer-related cardiovascular disease.

Why This Course Stands Out

✔ Comprehensive Cardio-Oncology Education

✔ Advanced Cardiomyopathy Management

✔ Cardiac Amyloidosis Treatment Updates

✔ Hypertrophic Cardiomyopathy Review

✔ Cardiac Sarcoidosis Diagnosis & Therapy

✔ Genetic Cardiomyopathy Evaluation

✔ Cancer Therapy Cardiotoxicity Monitoring

✔ Cardiac MRI & Advanced Imaging

✔ Venous Thromboembolism in Cancer

✔ Cancer Survivor Cardiovascular Care

✔ Multidisciplinary Clinical Approach

✔ Expert National Faculty

Who Should Take This Course?

This symposium is particularly valuable for:

• Cardiologists

• Heart Failure Specialists

• Oncologists

• Hematologists

• Cardio-Oncology Providers

• Advanced Practice Providers

• Healthcare professionals involved in cardiovascular care of cancer patients

Clinical & Educational Value

The Scripps 7th Annual Cardiomyopathy and Cardio-Oncology Symposium 2024 delivers a comprehensive review of two of the fastest-growing fields in cardiovascular medicine. By combining updates in cardiac amyloidosis, hypertrophic cardiomyopathy, genetic heart disease, and cardio-oncology, the course equips clinicians with practical knowledge to improve outcomes for patients with complex cardiovascular and oncologic conditions.

Topics:

• brochure_cmp24.pdf
• SESSION I Cancer-Associated Thrombosis.mp4
• SESSION I Cardiotoxicity Anthracyclines.mp4
• SESSION I Cardiotoxicity Immunotherapy.mp4
• SESSION I Comprehensive Management of PE.mp4
• SESSION I Diagnosis of Sarcoid.mp4
• SESSION I HCM-Diagnosis and Treatment.mp4
• SESSION I Imaging of Sarcoid.mp4
• SESSION I MRI Imaging in Cardiotoxicity.mp4
• SESSION I Panel Discussion Q&A.mp4
• SESSION I Treatment of Sarcoid.mp4
• SESSION II Cardiac Amyloidosis Mimickers.mp4
• SESSION II MRI Imaging in Amyloid.mp4
• SESSION II Nuclear Imaging in Amyloid.mp4
• SESSION II Panel Discussion Q&A.mp4
• SESSION II What and When to Biopsy.mp4
• SESSION II When is MGUS Clinically Significant.mp4
• SESSION II When to Suspect Amyloidosis.mp4
• SESSION III AL Amyloidosis Current Treatments.mp4
• SESSION III Current Treatment of ATTR Silencers.mp4
• SESSION III Current Treatment of ATTR Stabilizers.mp4
• SESSION III Emerging ATTR Treatments.mp4
• SESSION III Panel Discussion Q&A.mp4
• SESSION III Racial and Geographic Disparities in Amyloid.mp4
• SESSION III Staging in Amyloid.mp4
• SESSION IV Carpal Tunnel in Amyloid.mp4
• SESSION IV Managing GI Issues in Amyloidosis.mp4
• SESSION IV Neuropathy and Dysautonomia in Amyloid.mp4
• SESSION IV Panel Discussion Q&A.mp4
• SESSION IV Transplant in Amyloidosis.mp4